Comprehensive Analysis of the Expression, Prognosis, and Biological Significance of OVOLs in Breast Cancer

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhao S, Gan L, Zhuang Z. Bioinformatics analysis of prognostic value of PITX1 gene in breast cancer. Biosci Rep. 2020;40(9):BSR20202537. doi:10.1042/BSR20202537
   PubMed Web of Science ®Google Scholar
• Duffy MJ, Walsh S, McDermott EW, Crown J. Biomarkers in breast cancer: where are we and where are we going? Adv Clin Chem. 2015;71:1–23.
   PubMed Web of Science ®Google Scholar
• Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747–752. doi:10.1038/35021093
   PubMed Web of Science ®Google Scholar
• Slamon DJ, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med. 2001;344(11):783–792. doi:10.1056/NEJM200103153441101
   PubMed Web of Science ®Google Scholar
• Tsuji G, Ito T, Chiba T, et al. The role of the OVOL1-OVOL2 axis in normal and diseased human skin. J Dermatol Sci. 2018;90(3):227–231. doi:10.1016/j.jdermsci.2018.02.005
   PubMed Web of Science ®Google Scholar
• Kumar A, Bhandari A, Sinha R, et al. Molecular phylogeny of OVOL genes illustrates a conserved C2H2 zinc finger domain coupled by hypervariable unstructured regions. PLoS One. 2012;7(6):e39399–e39399. doi:10.1371/journal.pone.0039399
   PubMed Web of Science ®Google Scholar
• Nieto MA. The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol. 2011;27:347–376. doi:10.1146/annurev-cellbio-092910-154036
   PubMed Web of Science ®Google Scholar
• Li S, Yang J. Ovol proteins: guardians against EMT during epithelial differentiation. Dev Cell. 2014;29(1):1–2. doi:10.1016/j.devcel.2014.04.002
   PubMed Web of Science ®Google Scholar
• Roca H, Hernandez J, Weidner S, et al. Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer. PLoS One. 2013;8(10):e76773. doi:10.1371/journal.pone.0076773
   PubMed Web of Science ®Google Scholar
• Liu J, Wu Q, Wang Y, et al. Ovol2 induces mesenchymal-epithelial transition via targeting ZEB1 in osteosarcoma. Onco Targets Ther. 2018;11:2963–2973. doi:10.2147/OTT.S157119
   PubMed Web of Science ®Google Scholar
• Wang ZH, Li Z, Hu M, et al. Ovol2 gene inhibits the epithelial-to-mesenchymal transition in lung adenocarcinoma by transcriptionally repressing Twist1. Gene. 2017;600:1–8. doi:10.1016/j.gene.2016.11.034
   PubMed Web of Science ®Google Scholar
• Song KA, Faber AC. OVOL2 in metastasis prevention in NPC. Theranostics. 2018;8(8):2242–2244. doi:10.7150/thno.25181
   PubMed Web of Science ®Google Scholar
• Saxena K, Srikrishnan S, Celia-Terrassa T, Jolly MK. OVOL1/2: drivers of epithelial differentiation in development, disease, and reprogramming. Cells Tissues Organs. 2020;1–10. doi:10.1159/000511383
   Web of Science ®Google Scholar
• Xu C, Yan T, Yang J. OVOL1 inhibits oral squamous cell carcinoma growth and metastasis by suppressing zinc finger E-box binding homeobox 1. Int J Clin Exp Pathol. 2019;12(7):2801–2808.
   PubMed Web of Science ®Google Scholar
• Qi XK, Han HQ, Zhang HJ, et al. OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma. Theranostics. 2018;8(8):2202–2216. doi:10.7150/thno.24003
   PubMed Web of Science ®Google Scholar
• Sun CC, Li SJ, Hu W, et al. Comprehensive analysis of the expression and prognosis for E2FS in human breast cancer. Mol Ther. 2019;27(6):1153–1165. doi:10.1016/j.ymthe.2019.03.019
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–w102. doi:10.1093/nar/gkx247
   PubMed Web of Science ®Google Scholar
• Vivian J, Rao AA, Nothaft FA, et al. Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol. 2017;35(4):314–316. doi:10.1038/nbt.3772
   PubMed Web of Science ®Google Scholar
• Liu J, Lichtenberg T, Hoadley KA, et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173(2):400–416.e411.
   PubMed Web of Science ®Google Scholar
• Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57. doi:10.1038/nprot.2008.211
   PubMed Web of Science ®Google Scholar
• Curtis C, Shah SP, Chin SF, et al. The genomic and transcriptomic architecture of 2000 breast tumours reveals novel subgroups. Nature. 2012;486(7403):346–352. doi:10.1038/nature10983
   PubMed Web of Science ®Google Scholar
• Ito T, Tsuji G, Ohno F, Nakahara T, Uchi H, Furue M. Potential role of the OVOL1-OVOL2 axis and c-Myc in the progression of cutaneous squamous cell carcinoma. Mod Pathol. 2017;30(7):919–927. doi:10.1038/modpathol.2016.169
   PubMed Web of Science ®Google Scholar
• Mitoma C, Nakahara T, Uchi H, et al. Preferential expression of OVOL1 in inner root sheath of hair, sebaceous gland, eccrine duct and their neoplasms in human skin. Fukuoka Igaku Zasshi. 2014;105(8):166–173.
   PubMedGoogle Scholar
• Fu H, Qi L, Chen L, He Y, Zhang N, Guo H. Expression of Ovol2 is related to epithelial characteristics and shows a favorable clinical outcome in hepatocellular carcinoma. Onco Targets Ther. 2016;9:5963–5973. doi:10.2147/OTT.S110409
   PubMed Web of Science ®Google Scholar
• Zhang R, Hong JJ, Yang Q, Ong CT, Li BA, Liou YC. Poly(ADP-ribosyl)ation of OVOL2 regulates aneuploidy and cell death in cancer cells. Oncogene. 2019;38(15):2750–2766. doi:10.1038/s41388-018-0615-3
   PubMed Web of Science ®Google Scholar
• Wu RS, Hong JJ, Wu JF, et al. OVOL2 antagonizes TGF-β signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis. Oncotarget. 2017;8(24):39401–39416. doi:10.18632/oncotarget.17031
   PubMedGoogle Scholar
• Ye GD, Sun GB, Jiao P, et al. OVOL2, an inhibitor of WNT signaling, reduces invasive activities of human and mouse cancer cells and is down-regulated in human colorectal tumors. Gastroenterology. 2016;150(3):659–671.e616. doi:10.1053/j.gastro.2015.11.041
   PubMed Web of Science ®Google Scholar
• Prat A, Parker JS, Fan C, Perou CM. PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer. Breast Cancer Res Treat. 2012;135(1):301–306. doi:10.1007/s10549-012-2143-0
   PubMed Web of Science ®Google Scholar
• Jubair S, Alkhateeb A, Tabl AA, Rueda L, Ngom A. A novel approach to identify subtype-specific network biomarkers of breast cancer survivability. Netw Model Anal Health Inform Bioinform. 2020;9(1):43. doi:10.1007/s13721-020-00249-4
   Web of Science ®Google Scholar